Status:
UNKNOWN
Comparison of Metformin and Pioglitazone in Regulating Menstrual Irregularities and Hyperandrogenism
Lead Sponsor:
Dow University of Health Sciences
Conditions:
Menstrual Irregularities
Hyperandrogenism
Eligibility:
FEMALE
18-40 years
Phase:
PHASE1
PHASE2
Brief Summary
To compare metformin with pioglitazone in improving menstrual irregularities and hyperandrogenism in women with PCOS so that an alternate and better treatment option will be available for hyperinsulin...
Detailed Description
This study will be a prospective, randomized, open label, multicentre study. It will be carried out in outpatients department of Obstetrics and gynecology, at the Dow university of Hospital and mamji ...
Eligibility Criteria
Inclusion
- women of age 18-40 with primary or secondary infertility.
- Polycystic ovarian syndrome daignosed using rotterdam criteria.
- Not taken any medication before for PCOS.
Exclusion
- Women having type 1 or type 2 diabetes mellitus.
- Abnormal kidney or liver function.
- Hypertension or heart disease.
- Gonadotrophin induction or ovarian drilling before will not be included in this study.
Key Trial Info
Start Date :
June 18 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2019
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT03757923
Start Date
June 18 2018
End Date
January 1 2019
Last Update
November 29 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dow University Hospital OJHA
Karachi, Sindh, Pakistan, 75270